Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment

Abstract Early in the COVID-19 pandemic, it emerged that the risk of severe outcomes was greater in patients with co-morbidities, including cancer. The huge effort undertaken to fight the pandemic, affects the management of cancer care, influencing their outcome. Despite the high fatality rate of CO...

Full description

Bibliographic Details
Main Authors: Concetta Meo, Giuseppe Palma, Francesca Bruzzese, Alfredo Budillon, Claudio Napoli, Filomena de Nigris
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Journal of Translational Medicine
Online Access:https://doi.org/10.1186/s12967-023-04110-w
_version_ 1827961103309602816
author Concetta Meo
Giuseppe Palma
Francesca Bruzzese
Alfredo Budillon
Claudio Napoli
Filomena de Nigris
author_facet Concetta Meo
Giuseppe Palma
Francesca Bruzzese
Alfredo Budillon
Claudio Napoli
Filomena de Nigris
author_sort Concetta Meo
collection DOAJ
description Abstract Early in the COVID-19 pandemic, it emerged that the risk of severe outcomes was greater in patients with co-morbidities, including cancer. The huge effort undertaken to fight the pandemic, affects the management of cancer care, influencing their outcome. Despite the high fatality rate of COVID-19 disease in cancer patients, rare cases of temporary or prolonged clinical remission from cancers after SARS-CoV-2 infection have been reported. We have reviewed sixteen case reports of COVID-19 disease with spontaneous cancer reduction of progression. Fourteen cases of remission following viral infections and two after anti-SARS-CoV-2 vaccination. The immune response to COVID-19, may be implicated in both tumor regression, and progression. Specifically, we discuss potential mechanisms which include oncolytic and priming hypotheses, that may have contributed to the cancer regression in these cases and could be useful for future options in cancer treatment.
first_indexed 2024-04-09T16:21:33Z
format Article
id doaj.art-692b51aa054246c299fee39169d6aa80
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-04-09T16:21:33Z
publishDate 2023-04-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-692b51aa054246c299fee39169d6aa802023-04-23T11:26:42ZengBMCJournal of Translational Medicine1479-58762023-04-0121111310.1186/s12967-023-04110-wSpontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatmentConcetta Meo0Giuseppe Palma1Francesca Bruzzese2Alfredo Budillon3Claudio Napoli4Filomena de Nigris5Department of Precision Medicine, School of Medicine, University of Campania “Luigi Vanvitelli”S.S.D. Sperimentazione Animale, Istituto Nazionale Tumori - IRCCS - Fondazione G. PascaleS.S.D. Sperimentazione Animale, Istituto Nazionale Tumori - IRCCS - Fondazione G. PascaleScientific Directorate - National Institute of Cancer - IRCCS - Fondazione G. PascaleClinical Department of Internal Medicine and Specialistic Units, Division of Clinical Immunology and Immunohematology, Transfusion Medicine, and Transplant Immunology (SIMT), Azienda Universitaria Policlinico (AOU)Department of Precision Medicine, School of Medicine, University of Campania “Luigi Vanvitelli”Abstract Early in the COVID-19 pandemic, it emerged that the risk of severe outcomes was greater in patients with co-morbidities, including cancer. The huge effort undertaken to fight the pandemic, affects the management of cancer care, influencing their outcome. Despite the high fatality rate of COVID-19 disease in cancer patients, rare cases of temporary or prolonged clinical remission from cancers after SARS-CoV-2 infection have been reported. We have reviewed sixteen case reports of COVID-19 disease with spontaneous cancer reduction of progression. Fourteen cases of remission following viral infections and two after anti-SARS-CoV-2 vaccination. The immune response to COVID-19, may be implicated in both tumor regression, and progression. Specifically, we discuss potential mechanisms which include oncolytic and priming hypotheses, that may have contributed to the cancer regression in these cases and could be useful for future options in cancer treatment.https://doi.org/10.1186/s12967-023-04110-w
spellingShingle Concetta Meo
Giuseppe Palma
Francesca Bruzzese
Alfredo Budillon
Claudio Napoli
Filomena de Nigris
Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment
Journal of Translational Medicine
title Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment
title_full Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment
title_fullStr Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment
title_full_unstemmed Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment
title_short Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment
title_sort spontaneous cancer remission after covid 19 insights from the pandemic and their relevance for cancer treatment
url https://doi.org/10.1186/s12967-023-04110-w
work_keys_str_mv AT concettameo spontaneouscancerremissionaftercovid19insightsfromthepandemicandtheirrelevanceforcancertreatment
AT giuseppepalma spontaneouscancerremissionaftercovid19insightsfromthepandemicandtheirrelevanceforcancertreatment
AT francescabruzzese spontaneouscancerremissionaftercovid19insightsfromthepandemicandtheirrelevanceforcancertreatment
AT alfredobudillon spontaneouscancerremissionaftercovid19insightsfromthepandemicandtheirrelevanceforcancertreatment
AT claudionapoli spontaneouscancerremissionaftercovid19insightsfromthepandemicandtheirrelevanceforcancertreatment
AT filomenadenigris spontaneouscancerremissionaftercovid19insightsfromthepandemicandtheirrelevanceforcancertreatment